Skip to main content

Table 1 DMRs overlapping DAMEs

From: DAMEfinder: a method to detect differential allele-specific methylation

 

DMR state

Total DMRs

DMRs with DAMEs

DAMEs with DMRs

Gain/loss ASM

CIMP

Hyper

5040

2171

2789

2694/95

Hypo

1713

114

116

88/28

Non-CIMP

Hyper

3187

76

77

61/16

Hypo

10,033

88

88

64/24

  1. Hyper- or hypo-methylated DMR refers to the increase or decrease of methylation in cancers in comparison with paired normal samples, while gain or loss of ASM refers to whether cancers have more or less allele specificity than paired normal samples